BioCentury
ARTICLE | Clinical News

Daxas roflumilast: Additional Phase III data

September 7, 2009 7:00 AM UTC

Additional data from 2 double-blind, international Phase III trials (HERMES and AURA) showed that Daxas significantly improved mean pre-bronchodilator FEV1 by 48 mL vs. placebo (p<0.0001) and signific...